Exact Mass: 485.0537654000001
Exact Mass Matches: 485.0537654000001
Found 28 metabolites which its exact mass value is equals to given mass value 485.0537654000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-Pcpt-2'-O-Me-cAMP
C17H17ClN5O6PS (485.0325662000001)
6-<3-(2,6-dichlorophenyl)-5-hydroxymethyl-4-isoxazolecarboxamido>penicillanic acid|6beta-[3-(2,6-dichloro-phenyl)-5-hydroxymethyl-isoxazole-4-carbonylamino]-penicillanic acid|dicloxacillin active metabolite|[3-(2,6-dichloro-phenyl)-5-hydroxymethyl-isoxazol-4-yl]-penicillin
C19H17Cl2N3O6S (485.0215082000001)
Crizotinib (hydrochloride)
Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition[1][2][3].
ADENOSINE 5-DIPHOSPHATE, MONOSODIUM SALT DIHYDRATE
C10H18N5NaO12P2 (485.03248879999995)
N-(3-(TRIFLUOROMETHYL)-5-(4-METHYL-1H-IMIDAZOL-1-YL)PHENYL)-3-IODO-4-METHYLBENZAMIDE
CHIR-98014
C20H17Cl2N9O2 (485.08822019999997)
(E)-ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxoprop-1-en-1-yl)-1-Methyl-1H-indole-3-carboxylate
C24H24BrNO5 (485.08377540000004)
4-bromo-10-phenyl-10H-spiro[acridine-9,9-fluorene]
C31H20BrN (485.07790200000005)
Asciminib hydrochloride
C20H19Cl2F2N5O3 (485.0832948000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Omoconazole nitrate
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
4-[5-(3-Iodo-phenyl)-2-(4-methanesulfinyl-phenyl)-1H-imidazol-4-YL]-pyridine
5-O-[(S)-{[(4-Chlorophenyl)carbonyl]oxy}(Hydroxy)phosphoryl]adenosine
C17H17ClN5O8P (485.05032420000003)
2-[(5E)-5-[[3-(4-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid
C22H19N3O4S3 (485.0537654000001)
sodium 2-acetamido-2-deoxy-3-O-(6-O-sulfonato-beta-D-glucosyl)-beta-D-galactose
9-[(4aR,6R,7S)-2-hydroxy-7-methoxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-8-(4-chlorophenyl)sulfanylpurin-6-amine
C17H17ClN5O6PS (485.0325662000001)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-chlorobenzoate
C17H17ClN5O8P (485.05032420000003)
CID44216842
C22H20BrN3O3S (485.04086700000005)
CID44216842 (Cdc42-IN-1) is a potent Cdc42-selective guanine nucleotide binding lead inhibitor. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 1.0 and 1.2 μM in GTP binding assay, respectively. The EC50s for Cdc42 WT and Cdc42Q61L mutant are 0.3 and 0.5 μM in GDP binding assay, respectively. Use as a molecular probe[1].
(2s)-2-amino-3-{4-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy]phenyl}propanoic acid
8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-2h-chromen-5-ol
C23H20BrNO6 (485.04739200000006)
(2s)-3-(4-hydroxyphenyl)-2-[n-(3,4,5-trihydroxybenzoyl)-1-(3,4,5-trihydroxyphenyl)formamido]propanoic acid
8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-2h-chromen-5-ol
C23H20BrNO6 (485.04739200000006)